Insider Selling: ADC Therapeutics (NYSE:ADCT) Major Shareholder Sells $8,641,179.68 in Stock
ADC Therapeutics SA (NYSE:ADCT - Get Free Report) major shareholder Redmile Group, Llc sold 2,634,506 shares of ADC Therapeutics stock in a transaction that occurred on Thursday, April 2nd. The stock was sold at an average price of $3.28, for a total transaction of $8,641,179.68. Following the...